The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
Mohamad Mohty(Inserm), Nigel H. Russell(Nottingham University Hospitals NHS Trust), Gunnar Kvalheim(Oslo University Hospital), Rafael F. Duarte(Institut Català d'Oncologia), Kai Hübel(University Hospital Cologne), Sandra Croockewit(Radboud University Nijmegen)
Cited by 75
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859